Cited by 370Muscle metabolism and nutritionMetabolism, Diabetes, and CancerDiet, Metabolism, and Disease

Overactivation of S6 Kinase 1 as a Cause of Human Insulin Resistance During Increased Amino Acid Availability

Tremblay, Frédéric, Krebs, Michael, Dombrowski, Luce, Brehm, Attila, Bernroider, Elisabeth, Roth, Erich, Nowotny, Peter, Waldhäusl, Werner +2 more·2005·Diabetes

Abstract

To examine the molecular mechanisms by which plasma amino acid elevation impairs insulin action, we studied seven healthy men twice in random order during infusion of an amino acid mixture or saline (total plasma amino acid ∼6 vs. ∼2 mmol/l). Somatostatin-insulin-glucose clamps created conditions of low peripheral hyperinsulinemia (∼100 pmol/l, 0–180 min) and prandial-like peripheral hyperinsulinemia (∼430 pmol/l, 180–360 min). At low peripheral hyperinsulinemia, endogenous glucose production (EGP) did not change during amino acid infusion but decreased by ∼70% during saline infusion (EGP150–180 min 11 ± 1 vs. 3 ± 1 μmol · kg−1 · min−1, P = 0.001). Prandial-like peripheral hyperinsulinemia completely suppressed EGP during both protocols, whereas whole-body rate of glucose disappearance (Rd) was ∼33% lower during amino acid infusion (Rd 330–360 min 50 ± 4 vs. 75 ± 6 μmol · kg−1 · min−1, P = 0.002) indicating insulin resistance. In skeletal muscle biopsies taken before and after prandial-like peripheral hyperinsulinemia, plasma amino acid elevation markedly increased the ability of insulin to activate S6 kinase 1 compared with saline infusion (∼3.7- vs. ∼1.9-fold over baseline). Furthermore, amino acid infusion increased the inhibitory insulin receptor substrate-1 phosphorylation at Ser312 and Ser636/639 and decreased insulin-induced phosphoinositide 3-kinase activity. However, plasma amino acid elevation failed to reduce insulin-induced Akt/protein kinase B and glycogen synthase kinase 3α phosphorylation. In conclusion, amino acids impair 1) insulin-mediated suppression of glucose production and 2) insulin-stimulated glucose disposal in skeletal muscle. Our results suggest that overactivation of the mammalian target of rapamycin/S6 kinase 1 pathway and inhibitory serine phosphorylation of insulin receptor substrate-1 underlie the impairment of insulin action in amino acid–infused humans.

Integrity signals

Registry

Crossref · 10.2337/diabetes.54.9.2674

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Inhibition of mTOR/p70 S6K with rapamycin restores insulin sensitivity caused by amino acids in human skeletal muscle.

    “Inhibition of mTOR/p70 S6K with rapamycin restores insulin sensitivity caused by amino acids in human skeletal muscle [155,156].”

    From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [156]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tremblay, F., Krebs, M., Dombrowski, L., Brehm, A., Bernroider, E., Roth, E., Nowotny, P., Waldhäusl, W., Marette, A., & Roden, M.
Affiliations
  • Department of Physiology and Lipid Research Unit, Laval University Hospital Research Center, Ste-Foy, Québec, Canada
  • Medical University of Vienna (AT)
  • Université Laval (CA)
  • Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
  • Hanusch Hospital (AT)
Venue
Diabetes
Published
2005-09-01
Volume
54
Issue
9
Pages
2674-2684
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2165274499
Cited by
370
References
46
Citations by year
2026: 4 · 2025: 14 · 2024: 11 · 2023: 12 · 2022: 14 · 2021: 18 · 2020: 23 · 2019: 18 · 2018: 24 · 2017: 13 · 2016: 19 · 2015: 15 · 2014: 29 · 2013: 16 · 2012: 30
FWCI
6.23
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Novo Nordisk
  • Österreichische Diabetes Gesellschaft
  • National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Muscle metabolism and nutrition
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
insulin resistance, amino acid availability, S6 kinase 1, mTOR signaling, IRS-1, serine phosphorylation, phosphatidylinositol 3-kinase, Akt/protein kinase B, glycogen synthase kinase-3α, endogenous glucose production, glucose disposal, skeletal muscle, hyperinsulinemia, prandial insulin
MeSH terms
Adult, Amino Acids, Cells, Cultured, Enzyme Activation, Glucose, Humans, Insulin Resistance, Male, Phosphorylation, Muscle, Skeletal, Ribosomal Protein S6 Kinases, 70-kDa

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review